Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10303 7th DIA Japan Annual Meeting
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
7th DIA Japan Annual Meeting


Date(s) And Time(s):
Oct 28 2010 9:00AM - Oct 29 2010 5:45PM

Location:
Tower Hall Funabori
4-1-1 Funabori
Edogawa-ku
Tokyo
134-0091 Japan

Overview:

At a time when globalization of pharmaceutical development is moving extremely quickly, it is important to create an opportunity to consider what direction should be taken in Japan and Asia and where we should look to the future through the clarification of Japan’s role and contribution in global development. As keynote speakers, Dr. Fumimaro Takaku, President of Jichi Medical University, and Dr. Yasuo Ikeda, Professor, Life Science and Medical Bioscience, Faculty of Science and Engineering, Waseda University, both leading Japanese medical authorities, will present on “How to Nurture and Develop Products of Japanese Origin” and "Japan’s Capability in Global Develpment” respectively. In addition, Dr. Murray Lumpkin, FDA Deputy Commissioner for International and Special Programs, Dr. Thomas Lönngren, Executive Director of the European Medicines Agency, and Dr. Tatsuya Kondo, Chief Executive of the PMDA will have a discussion chaired by Professor Tatsuo Kurokawa, Graduate School of Pharmaceutical Sciences, Chiba University on “Expectations for the Role of Asia and Japan in Global Development.” Another session is planned to discuss wide-ranging topics among those working in regulatory authorities and within pharmaceutical development in industry.

Session topics during the two day workshop are as follows:
• Proof-of-concept and Dose-finding Studies in Global Development
• Pediatric Medicines
• Experience from the Pandemic Crisis
• Adaptive Design in Japan
• Quality Improvement; Lean Six Sigma
• Therapeutic Risk Management and Post-Marketing Surveillance
• Clinical Research

This conference aims to contribute to the further advancement of international clinical development by deepening the mutual understanding among those working in the pharmaceutical industry, academia and regulatory authorities.



Event Code:
10303

Contact Information:

For information contact Drug Information Association, LLC
Maruei Building 4F, 2-19-9 Iwamoto-cho, Chiyoda-ku, Tokyo 101-0032 Japan
Tel: 81-3-5833-8444 Fax: 81-3-5820-8448
Email: diajapan@diajapan.org